Baxter International Inc. (NYSE:BAX) went down by -3.22% from its latest closing price compared to the recent 1-year high of $95.19. The company’s stock price has collected -0.96% of loss in the last five trading sessions. Barron's reported on 09/10/20 that 3 Medical Device Stocks That Will Bounce Back, According to an Analyst
Is It Worth Investing in Baxter International Inc. (NYSE :BAX) Right Now?
Baxter International Inc. (NYSE:BAX) scored a price-to-earnings ratio above its average ratio, recording 57.47 x from its present earnings ratio. Plus, the 36-month beta value for BAX is at 0.75. Opinions of the stock are interesting as 13 analysts out of 19 who provided ratings for Baxter International Inc. declared the stock was a “buy,” while 1 rated the stock as “overweight,” 4 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $96.24, which is $15.74 above the current price. BAX currently public float of 505.52M and currently shorts hold a 0.76% ratio of that float. Today, the average trading volume of BAX was 3.09M shares.
BAX’s Market Performance
BAX stocks went down by -0.96% for the week, with a monthly drop of -3.58% and a quarterly performance of -5.27%, while its annual performance rate touched -7.37%. The volatility ratio for the week stands at 2.28% while the volatility levels for the past 30 days are set at 1.93% for Baxter International Inc.. The simple moving average for the period of the last 20 days is -4.14% for BAX stocks with a simple moving average of -6.21% for the last 200 days.
Analysts’ Opinion of BAX
Many brokerage firms have already submitted their reports for BAX stocks, with Argus repeating the rating for BAX by listing it as a “Hold.” The predicted price for BAX in the upcoming period, according to Argus is $117 based on the research report published on September 4th of the current year 2020.
Oppenheimer, on the other hand, stated in their research note that they expect to see BAX reach a price target of $100. The rating they have provided for BAX stocks is “Outperform” according to the report published on June 24th, 2020.
Stifel gave a rating of “ Buy” to BAX, setting the target price at $95 in the report published on March 19th of the current year.
BAX Trading at -5.21% from the 50-Day Moving Average
After a stumble in the market that brought BAX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -15.42% of loss for the given period.
Volatility was left at 1.93%, however, over the last 30 days, the volatility rate increased by 2.28%, as shares sank -3.81% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -8.63% lower at present.
During the last 5 trading sessions, BAX fell by -0.96%, which changed the moving average for the period of 200-days by -2.36% in comparison to the 20-day moving average, which settled at $83.83. In addition, Baxter International Inc. saw -3.72% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at BAX starting from FORSYTH JOHN D, who sold 310 shares at the price of $83.59 back on Sep 14. After this action, FORSYTH JOHN D now owns 33,969 shares of Baxter International Inc., valued at $25,913 using the latest closing price.
GAVIN JAMES R III, the Director of Baxter International Inc., sold 14,899 shares at $86.41 during a trade that took place back on Aug 03, which means that GAVIN JAMES R III is holding 39,508 shares at $1,287,366 based on the most recent closing price.
Stock Fundamentals for BAX
Current profitability levels for the company are sitting at:
- +16.79 for the present operating margin
- +43.01 for the gross margin
The net margin for Baxter International Inc. stands at +8.81. The total capital return value is set at 15.16, while invested capital returns managed to touch 8.18. Equity return is now at value 11.80, with 5.00 for asset returns.
Based on Baxter International Inc. (BAX), the company’s capital structure generated 75.63 points at debt to equity in total, while total debt to capital is 43.06. Total debt to assets is 32.77, with long-term debt to equity ratio resting at 15.90. Finally, the long-term debt to capital ratio is 67.48.
When we switch over and look at the enterprise to sales, we see a ratio of 4.05, with the company’s debt to enterprise value settled at 0.13. The receivables turnover for the company is 6.13 and the total asset turnover is 0.67. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.32.